Determining Best Potential Predictor during High-dose Progestin Therapy for Early Staged and Well-differentiated Endometrial Adenocarcinoma Using Semiquantitative Analysis Based on Image Processing and Immunohistochemistry-Reference-Cited by-同舟云学术

Determining Best Potential Predictor during High-dose Progestin Therapy for Early Staged and Well-differentiated Endometrial Adenocarcinoma Using Semiquantitative Analysis Based on Image Processing and Immunohistochemistry

Published:2011 Issue:2 Volume:78 Page:84-95
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Kamoi Seiryu¹,Ohaki Yoshiharu²,Mori Osamu²,Yamada Takashi¹,Fukunaga Masaharu³,Takeshita Toshiyuki¹

Affiliation:

1. Division of Reproductive Medicine, Perinatology and Gynecologic Oncology, Graduate School of Medicine, Nippon Medical School

2. Department of Surgical Pathology, Nippon Medical School Chiba Hokusoh Hospital

3. Department of Pathology, The Jikei University Daisan Hospital

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Link

http://www.jstage.jst.go.jp/article/jnms/78/2/78_2_84/_pdf

Reference14 articles.

1. 1. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ: Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997; 79: 320-327.

2. 2. Randall TC, Kurman RJ: Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997; 90: 434-440.

3. 3. Fujiwara H, Shibahara H, Usui R, et al.: Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma. Am J Reprod Immunol 2002; 47: 129-131.

4. 4. Kamoi S, Ohaki Y, Mori O, Kurose K, Fukunaga M, Takeshita T: Serial histological observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci- Review of more than 25 biopsies from 5 patients. Int J Gynecol Cancer 2008; 18: 1305-1314.

5. 5. Silverberg SG, Kurman RJ: Endometrial Carcinoma. In: Rosai, ed. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease: atlas of tumor pathology fascicle 3, 1992; pp 47-89, Armed Forces Institute of Pathology, Washington DC.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review;BioMed Research International;2022-09-27

2. Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia;Reproductive Sciences;2020-03-02

3. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta‐analysis;Acta Obstetricia et Gynecologica Scandinavica;2019-03-28

4. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review;Acta Obstetricia et Gynecologica Scandinavica;2019-03-18

5. Hormonal Treatment in Recurrent and Metastatic Gynaecological Cancers: A Review of the Current Literature;Current Oncology Reports;2013-10-05